JPMorgan downgrades Replimune stock rating after second FDA rejection
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- Huawei beats Apple and Samsung with new wide foldable
- Iko Uwais, Joe Taslim Lead Indonesia Joint Venture’s Slate as Asia Media Alliance Group and Nation Pictures Partner Up (EXCLUSIVE)
- Karol G Delivers Visually Stunning Show At Historic Coachella Headlining Concert
- Goldman Sachs downgrades Volaris stock rating citing engine issues
- From Number 10 To The Frontline: Paramount’s 5 Sends Boris Johnson To The Ukraine/Russia War
- Goldman Sachs upgrades LatAm Airlines stock on solid finances
News from Other Countries
🇬🇧 United Kingdom
- Uber adds fuel surcharge for non-EV fares in Australia amid petrol price rises
- We lost £3,000 after collapse of Ikea’s solar panel installer
- Rising fuel costs puts strain on transport charity